Informations:
Erreur:
ID
13221
Description
Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00781170
Lien
https://clinicaltrials.gov/show/NCT00781170
Mots-clés
Versions (1)
- 24/01/2016 24/01/2016 -
Téléchargé le
24 janvier 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Multiple Myeloma NCT00781170
Eligibility Multiple Myeloma NCT00781170
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Myeloma NCT00781170
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
multiple myeloma, tumor stage
Item
multiple myeloma stadium ii / iii acc. to salmon and durie
boolean
C0026764 (UMLS CUI [1])
C1300072 (UMLS CUI [2])
C1300072 (UMLS CUI [2])
informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
organ function, sct
Item
adequate organ function prior autologous respectively allogeneic sct
boolean
C0678852 (UMLS CUI [1])
C1504389 (UMLS CUI [2])
C1504389 (UMLS CUI [2])
hla-identical donor
Item
availability of hla-identical related or unrelated donor
boolean
C0019633 (UMLS CUI [1])
C0375877 (UMLS CUI [2])
C0375877 (UMLS CUI [2])
stem cell count
Item
availability of at least 2 x 10^6 cd34+ cells per kg bw of recipient for the autologous sct and at least 3 x 10^6 cd34+ cells for allogeneic sct
boolean
C2019894 (UMLS CUI [1])
age
Item
for mrd-sct: 18-66 years; for mud-sct: 18-55 years
boolean
C0001779 (UMLS CUI [1])
risk factors
Item
at age <55 years existence of risk factors that make an myeloablative allogeneic transplantation to risky
boolean
C0035648 (UMLS CUI [1])
informed consent
Item
consent of donor to give dli
boolean
C0021430 (UMLS CUI [1])
heart insufficiency
Item
severe heart insufficiency
boolean
C0018801 (UMLS CUI [1])
comorbidity
Item
cardiovascular diseases or severe concomitant diseases
boolean
C0009488 (UMLS CUI [1])
antibiotics
Item
active infections that need antibiotic therapy
boolean
C0003232 (UMLS CUI [1])
hiv or hepatitis
Item
positive for hiv or hepatitis
boolean
C0019682 (UMLS CUI [1])
C0019158 (UMLS CUI [2])
C0019158 (UMLS CUI [2])
malignancy
Item
malign secondary disease
boolean
C0006826 (UMLS CUI [1])
bilirubin
Item
limited liver function with total bilirubin > 1.5 uln
boolean
C1278039 (UMLS CUI [1])
transaminases
Item
increased transaminase > 3 uln
boolean
C0002594 (UMLS CUI [1])
creatinine
Item
increased serum creatinine > 2 mg/dl
boolean
C0201976 (UMLS CUI [1])
pregnant or lactating
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
hypersensitivity
Item
known hypersensitivity to fludarabine or melphalan
boolean
C0020517 (UMLS CUI [1,1])
C0059985 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0025241 (UMLS CUI [2,2])
C0059985 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0025241 (UMLS CUI [2,2])
study subject participation status
Item
participation in another trial
boolean
C2348568 (UMLS CUI [1])